GlobalData on MSN
Tandem secures FDA approval for Control-IQ+ use in pregnancy
The approval is based on findings from the CIRCUIT trial published in JAMA in October 2025.
Even within a few weeks of starting on Control-IQ by Tandem Diabetes Care, I knew that this new system that helps automate insulin dosing was the right choice and could help me better manage my ...
NEW ORLEANS--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced positive real-world data demonstrating immediate and ...
Tandem Diabetes Care, Inc. TNDM presented positive real-world data, showing immediate and continued benefits across a diverse group of people using the t:slim X2 insulin pump with the Control-IQ ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication of results from the Pediatric Artificial ...
SAN DIEGO -- An automatic insulin delivery system bolstered type 1 diabetes outcomes even among users who didn't follow recommendations on boluses for meals and other corrections, according to a ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation automated insulin delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results